Reed Smith Client Alerts

French competition authority to start investigations into potentially “excessive prices” in the healthcare market in the next weeks, following increasing scrutiny across Europe.

On 3 July 2017, the president of the French competition authority, Isabelle de Silva, indicated the intention of the authority to assess potentially “excessive prices” in the healthcare industry, during a press conference.

The competition authority will start the investigation in the next few weeks, following scrutiny by the European Commission and the UK into excessive pricing for cancer medicines and epilepsy drugs.